New strategy aims to stop rare head & neck melanoma from coming back

This study is testing a new treatment plan for a rare and aggressive form of head and neck melanoma that can be removed by surgery. The goal is to see if giving an immunotherapy drug (with or without another targeted drug) before surgery, and then continuing it after, can help keep the cancer from returning longer than the standard approach of surgery and radiation alone. The trial will involve 60 patients and will measure how long patients remain cancer-free after treatment.